Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTIPT: IPT with ACT in Ghanaian Schoolchildren
NCT01459146Phase 4Unknown
- Sponsor
- Navrongo Health Research Centre
- Start
- Dec 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of artemether + lumefantrine in malaria, schistosomiasis, sponsored by Navrongo Health Research Centre. Status: unknown.
02
Drugs
artemether + lumefantrine
03
Conditions
malariaschistosomiasis
Beyond the preview
Go deeper on NCT01459146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01459146.